COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1Life Healthcare, Inc. | Common | 68269G107 | 245 | 31,266 | SH | | SOLE | | 31,266 | 0 | 0 |
Abbott Laboratories | Common | 002824100 | 68,155 | 627,292 | SH | | SOLE | | 627,292 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 86,818 | 566,842 | SH | | SOLE | | 566,842 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 4,890 | 72,307 | SH | | SOLE | | 72,307 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 1,018 | 72,225 | SH | | SOLE | | 72,225 | 0 | 0 |
Adaptive Biotechnologies Corp. | Common | 00650F109 | 2,732 | 337,722 | SH | | SOLE | | 337,722 | 0 | 0 |
Addus HomeCare Corp. | Common | 006739106 | 6,965 | 83,632 | SH | | SOLE | | 83,632 | 0 | 0 |
Adicet Bio, Inc. | Common | 007002108 | 925 | 63,329 | SH | | SOLE | | 63,329 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 1,623 | 586,038 | SH | | SOLE | | 586,038 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 5,130 | 43,191 | SH | | SOLE | | 43,191 | 0 | 0 |
AlerisLife Inc. | Common | 33832D205 | 29 | 24,237 | SH | | SOLE | | 24,237 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 4,472 | 18,894 | SH | | SOLE | | 18,894 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 5,664 | 190,122 | SH | | SOLE | | 190,122 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 18,729 | 128,414 | SH | | SOLE | | 128,414 | 0 | 0 |
ALX Oncology Holdings Inc. | Common | 00166B105 | 536 | 66,211 | SH | | SOLE | | 66,211 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 133,430 | 548,418 | SH | | SOLE | | 548,418 | 0 | 0 |
AMN Healthcare Services, Inc. | Common | 001744101 | 6,714 | 61,201 | SH | | SOLE | | 61,201 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 14,117 | 312,192 | SH | | SOLE | | 312,192 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 81 | 32,461 | SH | | SOLE | | 32,461 | 0 | 0 |
Arcutis Biotherapeutics, Inc. | Common | 03969K108 | 3,173 | 148,874 | SH | | SOLE | | 148,874 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 318 | 539,408 | SH | | SOLE | | 539,408 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 14,570 | 38,456 | SH | | SOLE | | 38,456 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 5,524 | 156,875 | SH | | SOLE | | 156,875 | 0 | 0 |
Arvinas, Inc. | Common | 04335A105 | 3,620 | 85,997 | SH | | SOLE | | 85,997 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 6,302 | 67,794 | SH | | SOLE | | 67,794 | 0 | 0 |
Assertio Holdings, Inc. | Common | 04546C205 | 1,211 | 410,575 | SH | | SOLE | | 410,575 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 74,312 | 1,124,741 | SH | | SOLE | | 1,124,741 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 1,634 | 162,599 | SH | | SOLE | | 162,599 | 0 | 0 |
Avidity Biosciences, Inc. | Common | 05370A108 | 1,238 | 85,218 | SH | | SOLE | | 85,218 | 0 | 0 |
Beam Therapeutics Inc. | Common | 07373V105 | 612 | 15,817 | SH | | SOLE | | 15,817 | 0 | 0 |
Becton, Dickinson and Company | Common | 075887109 | 18,226 | 73,930 | SH | | SOLE | | 73,930 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 8,257 | 51,018 | SH | | SOLE | | 51,018 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 7 | 6,000 | SH | | SOLE | | 6,000 | 0 | 0 |
Bicycle Therapeutics PLC | Sponsored ADS | 088786108 | 337 | 20,065 | SH | | SOLE | | 20,065 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 2,935 | 277,434 | SH | | SOLE | | 277,434 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 27,662 | 135,639 | SH | | SOLE | | 135,639 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 10,225 | 70,176 | SH | | SOLE | | 70,176 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 10,608 | 128,004 | SH | | SOLE | | 128,004 | 0 | 0 |
BioNTech SE | Sponsored ADS | 09075V102 | 14,171 | 95,042 | SH | | SOLE | | 95,042 | 0 | 0 |
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 325 | 131,990 | SH | | SOLE | | 131,990 | 0 | 0 |
Blueprint Medicines Corp. | Common | 09627Y109 | 5,613 | 111,118 | SH | | SOLE | | 111,118 | 0 | 0 |
Boston Scientific Corp. | Common | 101137107 | 29,638 | 795,215 | SH | | SOLE | | 795,215 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 60,271 | 782,735 | SH | | SOLE | | 782,735 | 0 | 0 |
Caribou Biosciences, Inc. | Common | 142038108 | 3,798 | 699,377 | SH | | SOLE | | 699,377 | 0 | 0 |
Cerevel Therapeutics Holdings, Inc. | Common | 15678U128 | 2,331 | 88,173 | SH | | SOLE | | 88,173 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 10,248 | 47,894 | SH | | SOLE | | 47,894 | 0 | 0 |
ChemoCentryx, Inc. | Common | 16383L106 | 1,938 | 78,197 | SH | | SOLE | | 78,197 | 0 | 0 |
Cigna Corp. | Common | 125523100 | 45,617 | 173,106 | SH | | SOLE | | 173,106 | 0 | 0 |
Cogent Biosciences, Inc. | Common | 19240Q201 | 1,325 | 146,911 | SH | | SOLE | | 146,911 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 331 | 88,335 | SH | | SOLE | | 88,335 | 0 | 0 |
Community Healthcare Trust Inc. | Common | 20369C106 | 540 | 14,900 | SH | | SOLE | | 14,900 | 0 | 0 |
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 39 | 154,310 | SH | | SOLE | | 154,310 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 3,347 | 55,080 | SH | | SOLE | | 55,080 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 11,472 | 123,803 | SH | | SOLE | | 123,803 | 0 | 0 |
Cytokinetics, Inc. | Common | 23282W605 | 4,711 | 119,898 | SH | | SOLE | | 119,898 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 31,577 | 124,556 | SH | | SOLE | | 124,556 | 0 | 0 |
Denali Therapeutics, Inc. | Common | 24823R105 | 6,546 | 222,420 | SH | | SOLE | | 222,420 | 0 | 0 |
Design Therapeutics, Inc. | Common | 25056L103 | 1,518 | 108,414 | SH | | SOLE | | 108,414 | 0 | 0 |
Dexcom, Inc. | Common | 252131107 | 9,680 | 129,884 | SH | | SOLE | | 129,884 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 651 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Edgewise Therapeutics, Inc. | Common | 28036F105 | 482 | 60,550 | SH | | SOLE | | 60,550 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 16,297 | 171,388 | SH | | SOLE | | 171,388 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 57,205 | 176,432 | SH | | SOLE | | 176,432 | 0 | 0 |
Elevance Health, Inc. | Common | 036752103 | 7,067 | 14,644 | SH | | SOLE | | 14,644 | 0 | 0 |
Embecta Corp. | Common | 29082K105 | 374 | 14,786 | SH | | SOLE | | 14,786 | 0 | 0 |
Endo International plc | Shares | G30401106 | 230 | 494,607 | SH | | SOLE | | 494,607 | 0 | 0 |
Fate Therapeutics, Inc. | Common | 31189P102 | 784 | 31,652 | SH | | SOLE | | 31,652 | 0 | 0 |
Fulcrum Therapeutics, Inc. | Common | 359616109 | 287 | 58,537 | SH | | SOLE | | 58,537 | 0 | 0 |
Fusion Pharmaceuticals Inc. | Common | 36118A100 | 108 | 43,394 | SH | | SOLE | | 43,394 | 0 | 0 |
G1 Therapeutics, Inc. | Common | 3621LQ109 | 2,094 | 423,869 | SH | | SOLE | | 423,869 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 1,168 | 898,374 | SH | | SOLE | | 898,374 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 102,034 | 1,650,765 | SH | | SOLE | | 1,650,765 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 1,964 | 174,897 | SH | | SOLE | | 174,897 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 14,179 | 351,484 | SH | | SOLE | | 351,484 | 0 | 0 |
Harpoon Therapeutics, Inc. | Common | 41358P106 | 496 | 259,910 | SH | | SOLE | | 259,910 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 20,890 | 124,303 | SH | | SOLE | | 124,303 | 0 | 0 |
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 14,521 | 113,230 | SH | | SOLE | | 113,230 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 421946104 | 2,829 | 104,024 | SH | | SOLE | | 104,024 | 0 | 0 |
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,972 | 70,662 | SH | | SOLE | | 70,662 | 0 | 0 |
HealthEquity, Inc. | Common | 42226A107 | 7,079 | 115,314 | SH | | SOLE | | 115,314 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 3,897 | 150,392 | SH | | SOLE | | 150,392 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 1,964 | 28,347 | SH | | SOLE | | 28,347 | 0 | 0 |
Horizon Therapeutics plc | Shares | G46188101 | 69,877 | 876,089 | SH | | SOLE | | 876,089 | 0 | 0 |
Humana Inc. | Common | 444859102 | 29,860 | 63,794 | SH | | SOLE | | 63,794 | 0 | 0 |
Icon plc | Shares | G4705A100 | 17,634 | 81,375 | SH | | SOLE | | 81,375 | 0 | 0 |
I-Mab | Sponsored ADS | 44975P103 | 1,837 | 162,580 | SH | | SOLE | | 162,580 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 18,557 | 52,910 | SH | | SOLE | | 52,910 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 36,143 | 196,047 | SH | | SOLE | | 196,047 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 3,011 | 58,180 | SH | | SOLE | | 58,180 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 719 | 52,067 | SH | | SOLE | | 52,067 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 13,895 | 243,437 | SH | | SOLE | | 243,437 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 21,311 | 106,176 | SH | | SOLE | | 106,176 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 6,504 | 175,680 | SH | | SOLE | | 175,680 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 18,293 | 84,303 | SH | | SOLE | | 84,303 | 0 | 0 |
iTeos Therapeutics, Inc. | Common | 46565G104 | 436 | 21,181 | SH | | SOLE | | 21,181 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 26,194 | 167,899 | SH | | SOLE | | 167,899 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 91,711 | 516,652 | SH | | SOLE | | 516,652 | 0 | 0 |
Karuna Therapeutics, Inc. | Common | 48576A100 | 10,002 | 79,057 | SH | | SOLE | | 79,057 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Shares | 500472303 | 3,548 | 164,790 | SH | | SOLE | | 164,790 | 0 | 0 |
Laboratory Corporation of America Holdings | Common | 50540R409 | 10,345 | 44,142 | SH | | SOLE | | 44,142 | 0 | 0 |
Lantheus Holdings, Inc. | Common | 516544103 | 8,392 | 127,092 | SH | | SOLE | | 127,092 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,998 | 182,293 | SH | | SOLE | | 182,293 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 52,429 | 160,722 | SH | | SOLE | | 160,722 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 6,287 | 411,743 | SH | | SOLE | | 411,743 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 1,412 | 9,435 | SH | | SOLE | | 9,435 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 29,274 | 326,172 | SH | | SOLE | | 326,172 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 50,337 | 552,122 | SH | | SOLE | | 552,122 | 0 | 0 |
Mereo BioPharma Group plc | ADS | 589492107 | 1,737 | 1,551,082 | SH | | SOLE | | 1,551,082 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 2,157 | 95,290 | SH | | SOLE | | 95,290 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 5,624 | 83,784 | SH | | SOLE | | 83,784 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 46,930 | 328,524 | SH | | SOLE | | 328,524 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 29,383 | 105,085 | SH | | SOLE | | 105,085 | 0 | 0 |
Morphic Holding, Inc. | Common | 61775R105 | 968 | 44,625 | SH | | SOLE | | 44,625 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 396 | 81,867 | SH | | SOLE | | 81,867 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 758 | 21,400 | SH | | SOLE | | 21,400 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 608 | 10,038 | SH | | SOLE | | 10,038 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 16,387 | 168,108 | SH | | SOLE | | 168,108 | 0 | 0 |
NexGel, Inc. | Common | 65344E107 | 7 | 4,243 | SH | | SOLE | | 4,243 | 0 | 0 |
Nkarta, Inc. | Common | 65487U108 | 357 | 28,988 | SH | | SOLE | | 28,988 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 11,515 | 136,225 | SH | | SOLE | | 136,225 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 3,281 | 63,800 | SH | | SOLE | | 63,800 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 14,544 | 130,523 | SH | | SOLE | | 130,523 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 8,638 | 306,433 | SH | | SOLE | | 306,433 | 0 | 0 |
Owens & Minor, Inc. | Common | 690732102 | 9,063 | 288,167 | SH | | SOLE | | 288,167 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 2,078 | 51,224 | SH | | SOLE | | 51,224 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 59,356 | 1,132,103 | SH | | SOLE | | 1,132,103 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 8,651 | 495,733 | SH | | SOLE | | 495,733 | 0 | 0 |
Praxis Precision Medicines, Inc. | Common | 74006W108 | 184 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
Precision BioSciences, Inc. | Common | 74019P108 | 359 | 224,534 | SH | | SOLE | | 224,534 | 0 | 0 |
Prometheus Biosciences, Inc. | Common | 74349U108 | 1,389 | 49,195 | SH | | SOLE | | 49,195 | 0 | 0 |
Protagonist Therapeutics, Inc. | Common | 74366E102 | 967 | 122,271 | SH | | SOLE | | 122,271 | 0 | 0 |
Pyxis Oncology, Inc. | Common | 747324101 | 1,686 | 708,303 | SH | | SOLE | | 708,303 | 0 | 0 |
Qiagen N.V. | Shares | N72482123 | 496 | 10,500 | SH | | SOLE | | 10,500 | 0 | 0 |
R1 RCM Inc. | Common | 77634L105 | 4,241 | 202,351 | SH | | SOLE | | 202,351 | 0 | 0 |
Rallybio Corporation | Common | 75120L100 | 14,580 | 1,931,120 | SH | | SOLE | | 1,931,120 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 84,451 | 142,864 | SH | | SOLE | | 142,864 | 0 | 0 |
Repare Therapeutics Inc. | Common | 760273102 | 408 | 29,150 | SH | | SOLE | | 29,150 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 14,884 | 70,999 | SH | | SOLE | | 70,999 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 7,134 | 510,660 | SH | | SOLE | | 510,660 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 6,176 | 123,454 | SH | | SOLE | | 123,454 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 15,904 | 212,165 | SH | | SOLE | | 212,165 | 0 | 0 |
Scholar Rock Holding Corp. | Common | 80706P103 | 597 | 108,833 | SH | | SOLE | | 108,833 | 0 | 0 |
Seagen Inc. | Common | 81181C104 | 34,536 | 195,183 | SH | | SOLE | | 195,183 | 0 | 0 |
Smith & Nephew plc | Sponsored ADR | 83175M205 | 5,073 | 181,710 | SH | | SOLE | | 181,710 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 15,534 | 209,154 | SH | | SOLE | | 209,154 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 89 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 3,436 | 16,669 | SH | | SOLE | | 16,669 | 0 | 0 |
Stevanato Group Societa' Per Azioni | Ordinary Shares | T9224W109 | 1,126 | 71,190 | SH | | SOLE | | 71,190 | 0 | 0 |
Stryker Corp. | Common | 863667101 | 44,894 | 225,678 | SH | | SOLE | | 225,678 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 854 | 163,924 | SH | | SOLE | | 163,924 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 1,087 | 56,480 | SH | | SOLE | | 56,480 | 0 | 0 |
Syneos Health, Inc. | Class A | 87166B102 | 21,715 | 302,945 | SH | | SOLE | | 302,945 | 0 | 0 |
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 1,475 | 105,073 | SH | | SOLE | | 105,073 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 3,457 | 459,651 | SH | | SOLE | | 459,651 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 53,027 | 97,605 | SH | | SOLE | | 97,605 | 0 | 0 |
Theseus Pharmaceuticals, Inc. | Common | 88369M101 | 553 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Travere Therapeutics, Inc. | Common | 89422G107 | 6,001 | 247,678 | SH | | SOLE | | 247,678 | 0 | 0 |
TScan Therapeutics, Inc. | Common | 89854M101 | 629 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 2,647 | 44,365 | SH | | SOLE | | 44,365 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 9,724 | 521,693 | SH | | SOLE | | 521,693 | 0 | 0 |
United Therapeutics Corp. | Common | 91307C102 | 17,015 | 72,206 | SH | | SOLE | | 72,206 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 164,110 | 319,510 | SH | | SOLE | | 319,510 | 0 | 0 |
Universal Health Realty Income Trust | Shares | 91359E105 | 599 | 11,258 | SH | | SOLE | | 11,258 | 0 | 0 |
Universal Health Services, Inc. | Class B | 913903100 | 403 | 4,000 | SH | | SOLE | | 4,000 | 0 | 0 |
VectivBio Holding AG | Ordinary Shares | H9060V101 | 4,085 | 756,502 | SH | | SOLE | | 756,502 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 12,761 | 248,131 | SH | | SOLE | | 248,131 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 3,150 | 751,905 | SH | | SOLE | | 751,905 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 101,791 | 361,231 | SH | | SOLE | | 361,231 | 0 | 0 |
VYNE Therapeutics Inc. | Common | 92941V209 | 53 | 135,395 | SH | | SOLE | | 135,395 | 0 | 0 |
Waters Corp. | Common | 941848103 | 1,192 | 3,600 | SH | | SOLE | | 3,600 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 16,724 | 203,083 | SH | | SOLE | | 203,083 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 6,487 | 236,996 | SH | | SOLE | | 236,996 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 904 | 29,710 | SH | | SOLE | | 29,710 | 0 | 0 |
Zai Lab Ltd. | ADR | 98887Q104 | 1,502 | 43,300 | SH | | SOLE | | 43,300 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 14,923 | 142,044 | SH | | SOLE | | 142,044 | 0 | 0 |
ZimVie Inc. | Common | 98888T107 | 227 | 14,202 | SH | | SOLE | | 14,202 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 25,219 | 146,714 | SH | | SOLE | | 146,714 | 0 | 0 |